"モデルナ社" の関連情報検索結果

FDA Refuses to Review Moderna Flu Shot in Surprise Setback - Bloomberg.com



FDA Refuses to Review Moderna Flu Shot in Surprise Setback  Bloomberg.com

Moderna says FDA refuses its application for new mRNA flu vaccine - AP News



Moderna says FDA refuses its application for new mRNA flu vaccine  AP News

How Moderna, the company that helped save the world, unraveled - statnews.com



How Moderna, the company that helped save the world, unraveled  statnews.com

Pfizer, Moderna defend COVID vaccine effectiveness after Trump remarks - Reuters



Pfizer, Moderna defend COVID vaccine effectiveness after Trump remarks  Reuters

New Chassis For Application: Terrana Biosciences Emerges From Stealth Mode - thedailyscoop.com



New Chassis For Application: Terrana Biosciences Emerges From Stealth Mode  thedailyscoop.com

Carisma Therapeutics Amends Agreement with Moderna - TipRanks



Carisma Therapeutics Amends Agreement with Moderna  TipRanks

Science of mRNA - Moderna



Science of mRNA  Moderna

What’s Next for mRNA Vaccines? - Genetic Engineering and Biotechnology News



What’s Next for mRNA Vaccines?  Genetic Engineering and Biotechnology News

The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know - World Health Organization (WHO)



The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know  World Health Organization (WHO)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - The New England Journal of Medicine



Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine  The New England Journal of Medicine

Gates Foundation bets big on Moderna’s mRNA technology - Drug Discovery News



Gates Foundation bets big on Moderna’s mRNA technology  Drug Discovery News

Moderna’s path to vaccine innovation: A talk with CEO Stéphane Bancel - McKinsey & Company



Moderna’s path to vaccine innovation: A talk with CEO Stéphane Bancel  McKinsey & Company

At Moderna, OpenAI’s GPTs Are Changing Almost Everything - The Wall Street Journal



At Moderna, OpenAI’s GPTs Are Changing Almost Everything  The Wall Street Journal

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports ...



Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports  Reuters

Prasad overruled FDA staff to reject Moderna’s flu vaccine application - statnews.com



Prasad overruled FDA staff to reject Moderna’s flu vaccine application  statnews.com

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase - The New England Jou...



Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase  The New England Journal of Medicine

Moderna expects CDC to view its RSV vaccine as equal to rival shots - Reuters



Moderna expects CDC to view its RSV vaccine as equal to rival shots  Reuters

FDA refuses to review Moderna's influenza vaccine application - Reuters



FDA refuses to review Moderna's influenza vaccine application  Reuters

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June - Reuters



Moderna says its vaccine for ages under 6 will be ready for U.S. review in June  Reuters

Bird flu concern prompts US to award Moderna $176 million for vaccine development - Reuters



Bird flu concern prompts US to award Moderna $176 million for vaccine development  Reuters

In world first, South Africa's Afrigen makes mRNA COVID vaccine using Moderna data - Reuters



In world first, South Africa's Afrigen makes mRNA COVID vaccine using Moderna data  Reuters

FDA won’t review Moderna’s application for first mRNA-based flu vaccine - The Washington Post



FDA won’t review Moderna’s application for first mRNA-based flu vaccine  The Washington Post

Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds - Reuters



Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds  Reuters

White House sees decision on Moderna COVID shot for kids under 5 in next few weeks - Reuters



White House sees decision on Moderna COVID shot for kids under 5 in next few weeks  Reuters

Moderna, Thermo Fisher partner to manufacture COVID vaccine, other drugs - Reuters



Moderna, Thermo Fisher partner to manufacture COVID vaccine, other drugs  Reuters

Moderna says its COVID-19 shot 93% effective six months after second dose - Reuters



Moderna says its COVID-19 shot 93% effective six months after second dose  Reuters

Pfizer wins pause on Moderna's COVID-19 patent lawsuit - Reuters



Pfizer wins pause on Moderna's COVID-19 patent lawsuit  Reuters

Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents - Reuters



Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents  Reuters

This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines - S...



This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines  Science | AAAS

HHS cancels funding for Moderna to develop vaccines to combat bird flu - The Washington Post



HHS cancels funding for Moderna to develop vaccines to combat bird flu  The Washington Post

French health authority advises against Moderna COVID-19 vaccine for under 30s - Reuters



French health authority advises against Moderna COVID-19 vaccine for under 30s  Reuters

Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine - statnews.com



Lavishly funded Moderna hits safety problems in bold bid to revolutionize medicine  statnews.com

Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups - Reuters



Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups  Reuters

Foreign matter in Moderna COVID vaccine identified as stainless metal - Japan Wire by KYODO NEWS



Foreign matter in Moderna COVID vaccine identified as stainless metal  Japan Wire by KYODO NEWS

Moderna says mRNA flu vaccine sailed through trial, beating standard shot - Ars Technica



Moderna says mRNA flu vaccine sailed through trial, beating standard shot  Ars Technica

Chinese researchers find bat virus enters human cells via same pathway as COVID - Reuters



Chinese researchers find bat virus enters human cells via same pathway as COVID  Reuters

FDA adds warning about rare heart inflammation to Pfizer, Moderna COVID shots - Reuters



FDA adds warning about rare heart inflammation to Pfizer, Moderna COVID shots  Reuters

Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups - statnews.com



Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups  statnews.com

Many provinces withdraw COVID-19 shots, leaving gap as new ones await approval - The Globe and Mail



Many provinces withdraw COVID-19 shots, leaving gap as new ones await approval  The Globe and Mail

India govt won't buy Pfizer, Moderna vaccines amid local output -sources - Reuters



India govt won't buy Pfizer, Moderna vaccines amid local output -sources  Reuters

‘Now is the time’: Moderna co-founder and nutra experts on why delivery system innovation is key ...



‘Now is the time’: Moderna co-founder and nutra experts on why delivery system innovation is key for industry growth  NutraIngredients.com

Drugmakers sink after key FDA official ousted as Trump plans health overhaul - Reuters



Drugmakers sink after key FDA official ousted as Trump plans health overhaul  Reuters

MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY - Newswire Canada



MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY  Newswire Canada

Moderna to open vaccine facility in Laval in 2024 - CBC



Moderna to open vaccine facility in Laval in 2024  CBC

Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say - Reuters



Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say  Reuters

Moderna Therapeutics Scores Up to $25M DARPA Grant - Genetic Engineering and Biotechnology News



Moderna Therapeutics Scores Up to $25M DARPA Grant  Genetic Engineering and Biotechnology News

Moderna to launch skin cancer vaccine as soon as 2025: CEO - Nikkei Asia



Moderna to launch skin cancer vaccine as soon as 2025: CEO  Nikkei Asia